Eurofins Scientific (OTCMKTS:ERRFY) is a global leader in laboratory testing services, offering a broad spectrum of analytical and support solutions to clients across multiple industries. Founded in 1987 by Gilles Martin and headquartered in Luxembourg, the company has grown into one of the world’s largest networks of independent testing laboratories. Eurofins provides high-quality testing, research and advisory services designed to meet stringent regulatory and quality requirements.
The company’s core offerings span bio-analytical services for drug discovery and development, analytical chemistry for quality control, and microbiology testing for food safety. In addition, Eurofins delivers genomic and molecular diagnostics, environmental analysis, and specialty testing such as ecotoxicology and formulation development. These capabilities help clients ensure compliance, improve product safety, and accelerate innovation in sectors including pharmaceuticals, food and feed, cosmetics, environmental and agro-sciences.
Operating laboratories in more than 50 countries across Europe, North America, Asia-Pacific and Latin America, Eurofins supports both multinational corporations and local enterprises with standardized methodologies and local expertise. Strategic acquisitions and partnerships have driven the company’s rapid geographic expansion and broadened its portfolio of services, reinforcing its position as a trusted partner for customers worldwide.
Under the leadership of founder and Chairman Gilles Martin and Chief Executive Officer David Stanton, Eurofins continues to invest in cutting-edge technologies and expand its scientific capabilities. The company’s commitment to quality, innovation and sustainability underpins its long-term growth strategy and its mission to safeguard public health, support regulatory compliance and advance scientific discovery.
AI Generated. May Contain Errors.
